These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 639067)

  • 1. Effect of p-hydroxyacetanilide, sodium sulfate, and L-methionine on the leukemogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
    Cohen SM; Bryan GT
    Cancer Res; 1978 May; 38(5):1398-405. PubMed ID: 639067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of antibody-mediated and cell-mediated murine immunity by the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
    Headley DB; Cohen SM; Bryan GT
    Cancer Res; 1977 Apr; 37(4):974-9. PubMed ID: 14783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative carcinogenicity in Swiss mice of N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide and structurally related 5-nitrofurans and 4-nitrobenzenes.
    Cohen SM; Lower GM; Ertürk E; Bryan GT
    Cancer Res; 1973 Jul; 33(7):1593-7. PubMed ID: 4721223
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of leukemia and stomach neoplasms in Swiss, RF, BALB-c, and C3H female mice by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
    Cohen SM; Ertürk E; Bryan GT
    Cancer Res; 1970 Sep; 30(9):2320-5. PubMed ID: 5475478
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of adult thymectomy and adult splenectomy on the production of leukemia and stomach neoplasms in mice by N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide.
    Cohen SM; Headley DB; Bryan GT
    Cancer Res; 1973 Apr; 33(4):637-40. PubMed ID: 4696463
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinogenicity of 5-nitrofurans and related compounds with amino-heterocyclic substituents.
    Cohen S; Ertürk E; Von Esch A; Corvetti A; Bryan G
    J Natl Cancer Inst; 1975 Apr; 54(4):841-50. PubMed ID: 165300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of urinary bladder carcinomas in male hamsters by N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide, N-(4-(5-nitro-2-furyl)-2-thiazolyl)-acetamide, or formic acid 2-(4-(5-nitro-2-furyl)-2-thiazolyl)hydrazide.
    Croft WA; Bryan GT
    J Natl Cancer Inst; 1973 Sep; 51(3):941-9. PubMed ID: 4743562
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
    Ertürk E; Atassi SA; Yoshida O; Cohen SM; Price JM; Bryan GT
    J Natl Cancer Inst; 1970 Sep; 45(3):535-42. PubMed ID: 4331642
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats.
    Imaida K; Wang CY
    Cancer Res; 1986 Dec; 46(12 Pt 1):6160-4. PubMed ID: 3779637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice.
    Cohen SM; Ertürk E; Bryan GT
    Cancer Res; 1970 Apr; 30(4):906-12. PubMed ID: 4324549
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Fukushima S; Friedell GH; Jacobs JB; Cohen SM
    Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
    Sakata T; Hasegawa R; Johansson SL; Zenser TV; Cohen SM
    Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenicity of the antischistosomal nitrofuran trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-1,2,4-oxadiazole.
    Dunsford HA; Keysser CH; Dolan PM; Seed JL; Bueding E
    J Natl Cancer Inst; 1984 Jul; 73(1):151-60. PubMed ID: 6204093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic toxicity of 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide (AF-2) in mice, with special reference to carcinogenicity in the forestomach.
    Yokoro K; Kajihara H; Kodama Y; Nagao K; Hamada K; Kinomura A
    Gan; 1977 Dec; 68(6):825-8. PubMed ID: 598651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice.
    Ertürk E; Cohen SM; Bryan GT
    Cancer Res; 1970 May; 30(5):1309-11. PubMed ID: 5426933
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of the application mode of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide on the localization of its carcinogenic expression in female NMRI-mice.
    Berger MR; Petru E; Habs M; Schmähl D
    Cancer Lett; 1986 Jun; 31(3):311-8. PubMed ID: 3719571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazide and related chemicals in the rat.
    Ertürk E; Morris JE; Cohen SM; Von Esch AM; Crovetti AJ; Price JM; Bryan GT
    J Natl Cancer Inst; 1971 Aug; 47(2):437-45. PubMed ID: 5559244
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Cohen SM; Hasegawa R; Sakata T; Johansson SL
    Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Rice JR; Spry LA; Zenser TV; Davis BB
    Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    LaVoie EJ; Shigematsu A; Rivenson A; Mu B; Hoffmann D
    J Natl Cancer Inst; 1985 Dec; 75(6):1075-81. PubMed ID: 3865011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.